These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2690470)

  • 1. Renal handling of beta 2-microglobulin in patients with cystic fibrosis.
    Kearns GL; Berry PL; Bocchini JA; Hilman BC; Wilson JT
    DICP; 1989 Dec; 23(12):1013-7. PubMed ID: 2690470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and cimetidine. Urinary albumin and beta 2-microglobulin excretion and creatine clearance during cimetidine treatment.
    Christensen CK; Mogensen CE; Hanberg Sørensen F
    Scand J Gastroenterol; 1981; 16(1):129-34. PubMed ID: 6165069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption.
    de Jong PE; de Jong-van den Berg LT; Sewrajsingh GS; Schouten H; Donker AJ; Statius van Eps LW
    Nephron; 1981; 29(3-4):138-41. PubMed ID: 6173778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect.
    Bentur L; Kerem E; Couper R; Baumal R; Canny G; Durie P; Levison H
    J Pediatr; 1990 Apr; 116(4):556-60. PubMed ID: 1690795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in patients with cystic fibrosis.
    Aladjem M; Lotan D; Boichis H; Orda S; Katznelson D
    Nephron; 1983; 34(2):84-6. PubMed ID: 6866178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.
    Stehling F; Büscher R; Grosse-Onnebrink J; Hoyer PF; Mellies U
    Pulm Med; 2017; 2017():2602653. PubMed ID: 28133546
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S; Plant ND; Spencer DA
    J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.
    Flynn FV; Lapsley M; Sansom PA; Cohen SL
    J Clin Pathol; 1992 Jul; 45(7):561-7. PubMed ID: 1381383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides.
    Schentag JJ; Plaut ME
    Kidney Int; 1980 May; 17(5):654-61. PubMed ID: 6157048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha 1-microglobulin and its relationship to renal function.
    Kusano E; Suzuki M; Asano Y; Itoh Y; Takagi K; Kawai T
    Nephron; 1985; 41(4):320-4. PubMed ID: 2415841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compensatory changes in beta 2-microglobulin handling in the remnant tubules after contralateral nephrectomy. Observations of beta 2-microglobulin excretion into the urine].
    Higashi Y; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1985 Nov; 31(11):1897-905. PubMed ID: 3911767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.
    Jusko WJ; Mosovich LL; Gerbracht LM; Mattar ME; Yaffe SJ
    Pediatrics; 1975 Dec; 56(6):1038-44. PubMed ID: 1196754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of beta-2 microglobulinuria associated with gentamicin therapy.
    Kaye WA; Griffiths WC; Camara PD; Trebbin WM; Solomon RJ; Diamond I
    Ann Clin Lab Sci; 1981; 11(6):530-7. PubMed ID: 6173009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of cyclosporin A in children treated for idiopathic nephrotic syndrome.
    Tirelli AS; Paterlini G; Ghio L; Edefonti A; Assael BM; Bettinelli A; Cavanna G; Sereni F
    Acta Paediatr; 1993 May; 82(5):463-8. PubMed ID: 8518523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of aminoglycoside nephrotoxicity in cystic fibrosis patients.
    Godson C; Ryan MP; O'Halloran D; Bourke S; Brady HR; FitzGerald MX
    Scand J Gastroenterol Suppl; 1988; 143():70-3. PubMed ID: 3164514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of beta-2-microglobulin in neonates treated with gentamicin.
    Assadi FK; Chow-Tung E
    Nephron; 1988; 49(2):114-8. PubMed ID: 3288887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
    Dobson L; Stride A; Bingham C; Elworthy S; Sheldon CD; Hattersley AT
    Pediatr Pulmonol; 2005 Feb; 39(2):103-7. PubMed ID: 15573388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.